Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$16.69
-$0.43 (-2.5%)
Closing Price on November 25, 2024

TEVA Articles

Teva, Michael Kors, Sabre, and comScore all posted new 52-week lows Tuesday.
Teva Pharmaceutical saw its shares tumble on Tuesday after the company announced a changing of the guard. This CEO departure may have been long overdue.
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) saw its shares make a huge gain on Tuesday after the firm reported a key legal decision in its favor. Essentially, the U.S. District Court for the...
When pharmaceutical companies lose patent cases on the blockbuster drugs, it usually means that they are at risk of losing billions of dollars in drug sales.
The top analyst upgrades, downgrades and initiations seen on Tuesday include BP, Fitbit, Randgold Resources, SLM, Teva Pharmaceuticals, T-Mobile and GoPro.
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
DryShips, Teva, Endo Pharma, and Gilead Sciences posted new 52-week lows Monday.
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
Macy's, Teva, DryShips, Merrimack Pharma lead Wednesday's 52-week low club.
2016 was hard for biotech stocks, some more than others. These three present a buy low opportunity.
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
December 6, 2016: Here are four stocks trading with relatively heavy volume among 35 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by about 2.5 to 1...
Teva Pharmaceutical Industries shares sank on Tuesday after the company announced the appointment of Dipankar Bhattacharjee as chief executive for its global generic medicines group.
December 2, 2016: Here are four stocks trading with relatively heavy volume among 42 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by about 2.5 to 1 and...